Cleocin T

Product NDC
0009-3331
11-digit product format
000093331
Labeler code
0009
Product ID
0009-3331_a5273475-0e0d-437f-a074-a770aea6d302
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
clindamycin phosphate
Dosage form
GEL
Route
TOPICAL
Labeler
Pharmacia & Upjohn Company LLC
Application
NDA050615
Marketing category
NDA
Marketing start
1987-01-07
Marketing end
0000-00-00
Substance
CLINDAMYCIN PHOSPHATE
Active strength
10 mg/g
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Neuromuscular Blockade [PE]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0009-3331DDiscontinued by firm2026-08-17
excluded packagepackage0009-33310009-3331-01DDiscontinued by firm2026-08-17
excluded packagepackage0009-33310009-3331-02DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0009-3331-02d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0009-3331-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0009-3331-02f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0009-3331-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0009-3331-022ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0009-3331-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0009-3331-02a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0009-3331-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0009-3331-02cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0009-3331-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0009-3331-02cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0009-3331-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0009-3331-02302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0009-3331-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0009-3331-02ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0009-3331-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0009-3331-020efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0009-3331-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0009-3331-02ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0009-3331-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0009-3331-02367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0009-3331-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0009-3331-02557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0009-3331-01557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050615-001CLEOCIN TCLINDAMYCIN PHOSPHATEEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N050615-001AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-0731067a03dcf5…
2025-08-23 18:47 UTC2025-08N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-076a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-0703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-072680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-075bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-0779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-071e350fbaab3a…
2024-05-31 18:47 UTC2024-05N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-078072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-075c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-075d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-074b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-0774a2ff9319b5…
2022-03-09 01:35 UTC2022-03N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-0787673890dc5c…
2021-03-12 10:30 UTC2021-03N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-075aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-078869cabd3fbd…
2020-11-12 02:37 UTC2020-11N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-07c0c555d07b60…
2019-12-14 00:12 UTC2019-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-073f01610625f2…
2019-09-15 20:21 UTC2019-09N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-07b00525d2431f…
2019-07-19 19:46 UTC2019-07N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALABRLD, RS1987-01-07ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-076a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-071c564ffb4f44…
2023-12-20 04:57 UTC2023-12N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-079b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-073f0d92c62455…
2023-05-13 08:27 UTC2023-05N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07053a50430f4f…
2023-01-26 05:58 UTC2023-01N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-073bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-073a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N050615-001CLEOCIN TEQ 1% BASEGEL / TOPICALAB1RLD, RS1987-01-07e64feba35796…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07N050615-001AB11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N050615-001AB11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050615-001AB1131067a03dcf5…
2025-08-23 18:47 UTC2025-08N050615-001AB116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050615-001AB11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050615-001AB11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050615-001AB1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050615-001AB112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050615-001AB115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050615-001AB11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N050615-001AB11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050615-001AB1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050615-001AB11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050615-001AB111e350fbaab3a…
2024-05-31 18:47 UTC2024-05N050615-001AB118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050615-001AB115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N050615-001AB115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N050615-001AB114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N050615-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N050615-001AB11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N050615-001AB11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N050615-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03N050615-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N050615-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N050615-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N050615-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09N050615-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07N050615-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N050615-001AB116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N050615-001AB111c564ffb4f44…
2023-12-20 04:57 UTC2023-12N050615-001AB11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N050615-001AB11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N050615-001AB119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N050615-001AB11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N050615-001AB113f0d92c62455…
2023-05-13 08:27 UTC2023-05N050615-001AB11053a50430f4f…
2023-01-26 05:58 UTC2023-01N050615-001AB113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N050615-001AB113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N050615-001AB11f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N050615-001AB11e64feba35796…

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
1426d8f8-b7d5-4053-8554-613df00c0d86Product name220250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d8f81258-db12-0761-46cc-8ff6e62e9302Product name420240422
b7b2fa42-1c77-d724-81f0-87da60a77e79Product name320240320
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0Product name320230425
e3af9708-3004-7392-4046-5311eaa8bab5Product name320221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3Product name920220928
b72227d6-0388-43bd-995b-b762d2754cd5Product name120220706
a92d22e0-3af4-f301-bc88-27ff030b0070Product name220220316
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
5ce6ce33-4f2b-3ce0-757d-e520013280cfProduct name520180719
b92a26f1-6926-4817-be73-e26ab4c2146fProduct name120170602
028d6c95-5012-6976-2075-dee0ae6fefe2Product name120140508
468b2c08-8adb-8d0f-8257-c6515a061424Product name120140508
8959fb29-d86f-c521-666a-b4cb22233594Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0009-3331-01Cleocin T1 in 1 CARTONGEL130
0009-3331-01Cleocin T60 g in 1 TUBEGEL6030
0009-3331-02Cleocin T30 g in 1 TUBEGEL3030
0009-3331-02Cleocin T1 in 1 CARTONGEL130

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0009-3331-01GM - Gram0009-3331e0145e85-dee3-40c9-a3a3-0b8b136a2a0612012-07-24
0009-3331-02GM - Gram0009-33319ba379a8-b7b0-4ccc-a138-2635a833b70512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CLINDAMYCIN PHOSPHATEACTIVE INGREDIENTEH6D7113I8CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
CLINDAMYCINACTIVE MOIETY3U02EL437CCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
ALLANTOININACTIVE INGREDIENT344S277G0ZCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)INACTIVE INGREDIENTHHT01ZNK31CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1SCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
GLYCERININACTIVE INGREDIENTPDC6A3C0OXCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
ISOPROPYL ALCOHOLINACTIVE INGREDIENTND2M416302CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
ISOSTEARYL ALCOHOLINACTIVE INGREDIENTQ613OCQ44YCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32ICLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
SODIUM LAUROYL SARCOSINATEINACTIVE INGREDIENT632GS99618CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13
WATERINACTIVE INGREDIENT059QF0KO0RCLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0009-3331CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA & UPJOHN COMPANY LLC]29Legacy NDC, 4 package rows20230127_4a3901a4-194f-4a15-9c85-3d0982afcf31.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
clindamycin phosphateCLINDAMYCIN PHOSPHATEMylan Pharmaceuticals Inc.f7480256-8b32-419a-8983-e2c413040dba2025-12-12Warnings, Adverse reactionsExact identifier
application applno (NDA): 050615
application number: NDA050615
Cleocin TCLINDAMYCIN PHOSPHATEPharmacia & Upjohn Company LLC4a3901a4-194f-4a15-9c85-3d0982afcf312025-11-24Warnings, Adverse reactionsExact identifier
ndc (product): 0009-3331

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
804975Cleocin T 1 % Topical SolutionPSN4a3901a4-194f-4a15-9c85-3d0982afcf3130
804978Cleocin T 1 % Twice-Daily Topical GelPSN4a3901a4-194f-4a15-9c85-3d0982afcf3130
804973Cleocin-T 1 % Topical LotionPSN4a3901a4-194f-4a15-9c85-3d0982afcf3130
197519clindamycin phosphate 1 % Topical LotionPSN4a3901a4-194f-4a15-9c85-3d0982afcf3130
309333clindamycin phosphate 1 % Topical SolutionPSN4a3901a4-194f-4a15-9c85-3d0982afcf3130
2676585clindamycin phosphate 1 % Twice-Daily Topical GelPSN4a3901a4-194f-4a15-9c85-3d0982afcf3130
804973clindamycin 10 MG/ML Topical Lotion [Cleocin-T]SBD4a3901a4-194f-4a15-9c85-3d0982afcf3130
804975clindamycin 10 MG/ML Topical Solution [Cleocin-T]SBD4a3901a4-194f-4a15-9c85-3d0982afcf3130
804978Twice-Daily clindamycin 0.01 MG/MG Topical Gel [Cleocin-T]SBD4a3901a4-194f-4a15-9c85-3d0982afcf3130
197519clindamycin 10 MG/ML Topical LotionSCD4a3901a4-194f-4a15-9c85-3d0982afcf3130
309333clindamycin 10 MG/ML Topical SolutionSCD4a3901a4-194f-4a15-9c85-3d0982afcf3130
2676585Twice-Daily clindamycin 0.01 MG/MG Topical GelSCD4a3901a4-194f-4a15-9c85-3d0982afcf3130
804975Cleocin T Pledget 1 % Topical SolutionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804978Cleocin-T (as clindamycin phosphate) 1 % Topical GelSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804973Cleocin-T (as clindamycin phosphate) 1 % Topical LotionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804975Cleocin-T (as clindamycin phosphate) 1 % Topical SolutionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804978Cleocin-T 0.01 MG/MG Topical GelSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804973Cleocin-T 1 % Topical LotionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804975Cleocin-T 1 % Topical SolutionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804978Cleocin-T 1 % Twice-Daily Topical GelSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804973Cleocin-T 10 MG/ML Topical LotionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804975Cleocin-T 10 MG/ML Topical SolutionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
197519clindamycin (as clindamycin phosphate) 1 % Topical LotionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
309333clindamycin (as clindamycin phosphate) 1 % Topical SolutionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
2676585clindamycin (as clindamycin phosphate) 1 % Twice-Daily Topical GelSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
197519clindamycin 1 % Topical LotionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
309333clindamycin 1 % Topical SolutionSY4a3901a4-194f-4a15-9c85-3d0982afcf3130
804978Twice-Daily Cleocin-T 0.01 MG/MG Topical GelSY4a3901a4-194f-4a15-9c85-3d0982afcf3130

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0009-3331-01000093331011 TUBE in 1 CARTON (0009-3331-01) > 60 g in 1 TUBE1 tube1987-01-070000-00-00NoNoCurrent
0009-3331-02000093331021 TUBE in 1 CARTON (0009-3331-02) > 30 g in 1 TUBE1 tube1987-01-070000-00-00NoNoCurrent